Microglia morphology after Imaris-based threedimensional reconstruction in z-stacks from Cre/+ OIL (A) and Cre/+ TAM (B) cortical microglia. Distinct morphological changes of Iba1 + microglia 4 weeks after TAM-induced deletion of Tgfbr2 in Cre/+ TAM knockout mice were subdivided into "Bushy" and "Hypertrophied". Imaris-based automated quantification of microglial terminal points (B) and numbers of segments (C). Data are presented as means ± SEM of 20 cells in 3-4 animals per group. P-values derived from one-way ANOVA are *p<0.05, and ***p<0.001.
Supplementary Figure 4
TGFβ1-regulated expression of microglia surface receptors in vitro (A) Scheme illustrating the experimental strategy to obtain mRNA from control (serumfree culture medium, 24 h) and TGFβ1-treated (5 ng/ml, 24 h) primary microglia for cDNA microArrays. (A) Scheme illustrating the experimental strategy to obtain mRNA from control (serumfree culture medium, 24 h) and TGFβ1-treated (5 ng/ml, 24 h) primary microglia for cDNA microArrays. (B) Heatmap analysis showing log2 transformed fold changes of TGFβ1-regulated genes coding for cytokines, chemokines and respective receptors. Data are presented from 5 independent in vitro experiments. Fold changes with p<0.05 derived from paired Bayes t-test were included in the heatmap. (C) ELISA demonstrating reduced Cxcl10 release from TGFβ1-treated (5 ng/ml, 24 h) primary microglia. Data are given as means ± SEM from five independent experiments. P-value derived from one-sample t-tests is *p<0.05. (D) Heatmap illustrating TGFβ1-regulated microgliaspecific genes. Data are presented from as log2 fold changes from 5 independent experiments. Fold changes with p-values <0.05 derived from Bayes t-test were included in the depicted heatmap.
Supplementary methods

Microarray analysis
Integrity of RNA was analysed by capillary electrophoresis using a 2100 Bioanalyzer (Agilent Technologies, CA). Samples with an RNA integrity number (RIN) between 8.6 and 10 (mean 9.45) were further processed using the Affymetrix GeneChip Whole Transcript Sense Target Labeling Assay as described by the manufacturer. 500 ng of total RNA were reverse transcribed with (N6)-random primers coupled to a T7 RNA Polymerase promotor sequence. After second-strand synthesis, double-stranded cDNAs were amplified overnight by in-vitro-transcription using T7 RNA Polymerase. cRNA was purified and used as template for a second cycle of reverse transcription with (N6) random primers. dUTP was incorporated into the cDNA, and after hydrolysis of the cRNA with RNAse H, cDNA was purified and fragmented using Uracil-DNA Glycosylase (UDG) and human apurinic/apyrimidinic Endonuclease 1 (APE1). cDNA fragments were labeled at their 3' end with biotin using Terminal Deoxynucleotidyl Transferase (TdT).
Labeled fragments were hybridised to the arrays for 16h at 45°C with 60 rpm in an Affymetrix Hybridization oven 640. The arrays were scanned after washing and staining using the Affymetrix GeneChip Scanner 3000 7G. CEL-files were produced from the raw data with Affymetrix GeneChip Command Console Software Version 3.0. Genedata Expressionist software was further used for data analysis. CEL files were imported into the Refiner (Version 6.1) module of Expressionist where GC background subtraction was performed using antigenomic background probes. Quantile normalisation and probe summarisation was performed with the Bioconductor RMA condensing algorithm as implemented in Refiner 1 . Differentially expressed genes between the groups were identifed and the paired Bayes T-test (CyberT) 2 with the Bayes Confidence Estimate
Value set to 10 and a window size of 101 genes as well as 100 % valid values in each group was used (Analyst module, version 2.2.6b). Benjamini-Hochberg q-value was calculated 3 in order to control the false discovery rate. We then used the "2 groups paired" activity of Analyst to calculate the paired Effect size score between the experimental groups. Only genes from the categories "main" and "unmapped" (see Affymetrix transcript annotation NA32) were included in the analysis.
Microglia and blood monocyte isolation
Microglia were isolated using the Percoll gradient method. Blood monocytes were collected from 1 ml blood which was obtained from the left ventricle and transferred into a 2.0 ml tube containing 0.5M EDTA at 4°C. After centrifugation, the supernatant was discarded and 1mL 1X RBC Lysis buffer (00-4333-57, eBioscience) was added, followed by an incubation at 4°C for 10 min. Then 
ELISA
Levels of Cxcl10 in the medium of primary microglia were detected using an ELISA Development Kit (Peprotech, Hamburg, Germany) according to the manufacturer´s instructions. Colour reaction was performed using 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) substrate (ABTS, Sigma-Aldrich, Germany) for 30 minutes in the dark. Absorbance was detected using a Multiskan FC plate reader (Thermo Fischer) at the absorption of 405 nm. Concentrations of Cxcl10 were calculated from the standard curve using the GraphPad Prism6 software (GraphPad Software Inc.).
Sequencing
cDNA of primary microglia was amplified with primers Tgfbr2Seq forward 5′-TTAACTCGAGGGCTGCCATGGGTCG-3′, Tgfbr2Seq reverse 5′-GACGTCGACATTTTGGTAGTGTTCAGCA-3′. Purified PCR products were shipped for sequencing at GATC Biotech AG "LightRun" (www.gatc-biotech.com). Obtained sequences were analysed using SnapGene and NCBI BioSystems database (www.ncbi.nlm.nih.gov).
